1
For Expert help and assignment solutions, +254707240657
APHA Immunization Questions and
Answers (100% Correct Answers) Already
Graded A+
When Mary turned 64, she was diagnosed with type 2 diabetes. At
that time, she received PPSV23. Which of the following represents
appropriate pneumococcal coverage for Mary. [ ANS: ]
Administer PCV13 at age 65, then PPSV23 at age 69.
© 2025 Assignment Expert
LO 3.4; Module 3— Pneumococcal Disease, Vaccine
Recommendations Immunocompetent adults aged 65 years or
older should receive 13-valent pneumococcal conjugate vaccine
Guru01 - Stuvia
(PCV13) followed by 23-valent pneumococcal polysaccharide
vaccine (PPSV23) at least 1 year after PCV13. However, if an
individual is a candidate for PPSV23 prior to age 65 due to high-risk
conditions (in this case diabetes), then another dose of PPSV23
would be recommended after the individual turns 65, but should
be given 5 years after the 1st dose. Since Mary received PPSV23
prior to PCV13, then PCV13 should be administered at least one
year after PPSV23.
According to ACIP recommendations, HZV is indicated for the
prevention of herpes zoster in adults aged: [ ANS: ] 60
LO 3.2; Module 3—
Herpes Zoster, Target Groups for VaccinationEven though the
herpes zoster vaccine (Zostavax) is FDA approved for individuals
aged 50 and older, the ACIP recommends this vaccine for
individuals aged 60 and older. There are concerns about waning
immunity with this vaccine. If given too soon (before age 60), it
may not afford protection in older individuals who are at higher
risk of herpes zoster.
, 2
For Expert help and assignment solutions, +254707240657
In which publication does the CDC initially publish new or
updated vaccine recommendations? [ ANS: ] Morbidity and
Mortality Weekly Report (MMWR)
LO 1.6; Module 1—Vaccine Recommendation SourcesThe
Advisory Committee on Immunization Practices (ACIP) develops
vaccine recommendations and guidelines. These are reviewed
and approved by the CDC Director and the U.S. Department of
Health and Human Services. Once approved, they are published
in the CDC's Morbidity and Mortality Weekly Report (MMWR). The
© 2025 Assignment Expert
Epidemiology and Prevention of Vaccine-Preventable Diseases
(commonly referred to as the Pink Book) provides comprehensive
information about vaccines and the diseases they prevent.
Content published in the MMWR regarding vaccines is often
Guru01 - Stuvia
incorporated into this resource. Needle Tips is a newsletter
published multiple times throughout the year by the Immunization
Action Coalition. It provides timely updates and answers to
frequently asked questions. Vaccine is a journal affiliated with the
Edward Jenner Society and The Japanese Society for
Vaccinology. It is a forum for the publication of research, reviews,
and commentaries related to vaccines.
Which of the following best describes how to administer MMR
vaccine to an adult patient weighing 210 lb? [ ANS: ] Inject
subcutaneously at a 45° angle in the outer aspect of the upper
arm.
LO 4.10; Module 4— General Injection Principles The MMR vaccine
is administered subcutaneously at a 45 degree angle into the
outer aspect of the upper arm. Vaccines that are given
intramuscularly are administered into the deltoid muscle at a 90
degree angle. The weight of the patient does not matter with
regard to route of administration.
, 3
For Expert help and assignment solutions, +254707240657
The presence of fever, diffuse maculopapular rash, and Koplik
spots are characteristic of which of the following diseases? [ ANS: ]
Measles
Module 3—Measles, Mumps, Rubella. MeaslesThe classic
symptoms of measles include fever, cough, coryza (runny nose),
conjunctivitis, Koplik spots (a bluish-white rash on mucous
membranes, especially the mouth), followed by the development
of a maculopapular rash approximately 14 days after exposure.
Individuals infected with mumps may not have symptoms. Others
may have nonspecific symptoms, such as headache, fever,
myalgia, and malaise. About 30% to 40% of individuals may
© 2025 Assignment Expert
experience inflammation of the parotid glands. Rubella symptoms
tend to be relatively mild and may present as a maculopapular
rash that occurs approximately 14 days after exposure. Others
may experience arthritis and arthralgia. Varicella presents as a
Guru01 - Stuvia
generalized vesicular rash.
Which entity determines the specific vaccines that a pharmacist
may administer? [ ANS: ] State and yada
Module 1—Expanding Vaccination Offerings
A pharmacist's scope of practice and immunization authority are
determined by the pharmacist's state practice act. As such the
laws and regulations for pharmacists as immunizers vary by state.
The U.S. Food and Drug Administration provides the regulatory
oversight for the approval of vaccines. The Advisory Committee
on Immunization Practices is the leading authority in the U.S. that
provides comprehensive vaccination recommendations and
guidelines. These recommendations are reviewed and approved
by the CDC. The local health departments do not have any
oversight regarding a pharmacist's immunization practices.
However, pharmacists often work with their local health
departments to provide vaccines and public health services.
, 4
For Expert help and assignment solutions, +254707240657
Kyle is a 5-year-old boy who is up to date with his vaccinations. He
has never experienced any adverse effects from vaccinations. At
his next well-child check-up, Kyle will be receiving the following
vaccines: IPV, MMR, varicella vaccine, and a tetanus-containing
vaccine. Which of the following tetanus-containing vaccines
would be appropriate for him? [ ANS: ] DTaP
LO 3.4; Module 3—Target Groups for Vaccination. DTaP
VaccineDTaP is a five-dose series given at ages 2, 4, 6, 15 through
18 months, and 4 through 6 years. Kyle is due for his 5th and final
© 2025 Assignment Expert
dose of DTaP. DTaP is appropriate for children less than 7 years of
age. DT is only reserved for children who have a contraindication
to the pertussis component in DTaP. Children, adolescents, and
adults 7 years of age and older who require protection against
Guru01 - Stuvia
tetanus, diphtheria, and pertussis would receive Tdap. Following
the one-time dose of Tdap, a Td booster should be given every 10
years.
Which of the following documents must be given to every patient
or patient's caregiver before administration of a vaccine covered
under the National Childhood Vaccine Injury Act (NCVIA)? [ ANS:
] VIS
Module 4— Providing Vaccine Information StatementsVaccine
information statemetns (VISs) are standardized forms that provide
an overview of the risks and benefits of vaccines. Health care
providers who administer vaccines are required by law to provide
patients with the most up-to-date version of the VIS for any
vaccine covered under the National Childhood Vaccine Injury
Act (NCVIA). The CMS-1500 and CMS-855B are forms required by
the Centers for Medicare and Medicaid Services (CMS) for billing
and enrolling as a Medicare provider, respectively. The PHS-731 is
now the CDC 731 form and is the International Certificate of
For Expert help and assignment solutions, +254707240657
APHA Immunization Questions and
Answers (100% Correct Answers) Already
Graded A+
When Mary turned 64, she was diagnosed with type 2 diabetes. At
that time, she received PPSV23. Which of the following represents
appropriate pneumococcal coverage for Mary. [ ANS: ]
Administer PCV13 at age 65, then PPSV23 at age 69.
© 2025 Assignment Expert
LO 3.4; Module 3— Pneumococcal Disease, Vaccine
Recommendations Immunocompetent adults aged 65 years or
older should receive 13-valent pneumococcal conjugate vaccine
Guru01 - Stuvia
(PCV13) followed by 23-valent pneumococcal polysaccharide
vaccine (PPSV23) at least 1 year after PCV13. However, if an
individual is a candidate for PPSV23 prior to age 65 due to high-risk
conditions (in this case diabetes), then another dose of PPSV23
would be recommended after the individual turns 65, but should
be given 5 years after the 1st dose. Since Mary received PPSV23
prior to PCV13, then PCV13 should be administered at least one
year after PPSV23.
According to ACIP recommendations, HZV is indicated for the
prevention of herpes zoster in adults aged: [ ANS: ] 60
LO 3.2; Module 3—
Herpes Zoster, Target Groups for VaccinationEven though the
herpes zoster vaccine (Zostavax) is FDA approved for individuals
aged 50 and older, the ACIP recommends this vaccine for
individuals aged 60 and older. There are concerns about waning
immunity with this vaccine. If given too soon (before age 60), it
may not afford protection in older individuals who are at higher
risk of herpes zoster.
, 2
For Expert help and assignment solutions, +254707240657
In which publication does the CDC initially publish new or
updated vaccine recommendations? [ ANS: ] Morbidity and
Mortality Weekly Report (MMWR)
LO 1.6; Module 1—Vaccine Recommendation SourcesThe
Advisory Committee on Immunization Practices (ACIP) develops
vaccine recommendations and guidelines. These are reviewed
and approved by the CDC Director and the U.S. Department of
Health and Human Services. Once approved, they are published
in the CDC's Morbidity and Mortality Weekly Report (MMWR). The
© 2025 Assignment Expert
Epidemiology and Prevention of Vaccine-Preventable Diseases
(commonly referred to as the Pink Book) provides comprehensive
information about vaccines and the diseases they prevent.
Content published in the MMWR regarding vaccines is often
Guru01 - Stuvia
incorporated into this resource. Needle Tips is a newsletter
published multiple times throughout the year by the Immunization
Action Coalition. It provides timely updates and answers to
frequently asked questions. Vaccine is a journal affiliated with the
Edward Jenner Society and The Japanese Society for
Vaccinology. It is a forum for the publication of research, reviews,
and commentaries related to vaccines.
Which of the following best describes how to administer MMR
vaccine to an adult patient weighing 210 lb? [ ANS: ] Inject
subcutaneously at a 45° angle in the outer aspect of the upper
arm.
LO 4.10; Module 4— General Injection Principles The MMR vaccine
is administered subcutaneously at a 45 degree angle into the
outer aspect of the upper arm. Vaccines that are given
intramuscularly are administered into the deltoid muscle at a 90
degree angle. The weight of the patient does not matter with
regard to route of administration.
, 3
For Expert help and assignment solutions, +254707240657
The presence of fever, diffuse maculopapular rash, and Koplik
spots are characteristic of which of the following diseases? [ ANS: ]
Measles
Module 3—Measles, Mumps, Rubella. MeaslesThe classic
symptoms of measles include fever, cough, coryza (runny nose),
conjunctivitis, Koplik spots (a bluish-white rash on mucous
membranes, especially the mouth), followed by the development
of a maculopapular rash approximately 14 days after exposure.
Individuals infected with mumps may not have symptoms. Others
may have nonspecific symptoms, such as headache, fever,
myalgia, and malaise. About 30% to 40% of individuals may
© 2025 Assignment Expert
experience inflammation of the parotid glands. Rubella symptoms
tend to be relatively mild and may present as a maculopapular
rash that occurs approximately 14 days after exposure. Others
may experience arthritis and arthralgia. Varicella presents as a
Guru01 - Stuvia
generalized vesicular rash.
Which entity determines the specific vaccines that a pharmacist
may administer? [ ANS: ] State and yada
Module 1—Expanding Vaccination Offerings
A pharmacist's scope of practice and immunization authority are
determined by the pharmacist's state practice act. As such the
laws and regulations for pharmacists as immunizers vary by state.
The U.S. Food and Drug Administration provides the regulatory
oversight for the approval of vaccines. The Advisory Committee
on Immunization Practices is the leading authority in the U.S. that
provides comprehensive vaccination recommendations and
guidelines. These recommendations are reviewed and approved
by the CDC. The local health departments do not have any
oversight regarding a pharmacist's immunization practices.
However, pharmacists often work with their local health
departments to provide vaccines and public health services.
, 4
For Expert help and assignment solutions, +254707240657
Kyle is a 5-year-old boy who is up to date with his vaccinations. He
has never experienced any adverse effects from vaccinations. At
his next well-child check-up, Kyle will be receiving the following
vaccines: IPV, MMR, varicella vaccine, and a tetanus-containing
vaccine. Which of the following tetanus-containing vaccines
would be appropriate for him? [ ANS: ] DTaP
LO 3.4; Module 3—Target Groups for Vaccination. DTaP
VaccineDTaP is a five-dose series given at ages 2, 4, 6, 15 through
18 months, and 4 through 6 years. Kyle is due for his 5th and final
© 2025 Assignment Expert
dose of DTaP. DTaP is appropriate for children less than 7 years of
age. DT is only reserved for children who have a contraindication
to the pertussis component in DTaP. Children, adolescents, and
adults 7 years of age and older who require protection against
Guru01 - Stuvia
tetanus, diphtheria, and pertussis would receive Tdap. Following
the one-time dose of Tdap, a Td booster should be given every 10
years.
Which of the following documents must be given to every patient
or patient's caregiver before administration of a vaccine covered
under the National Childhood Vaccine Injury Act (NCVIA)? [ ANS:
] VIS
Module 4— Providing Vaccine Information StatementsVaccine
information statemetns (VISs) are standardized forms that provide
an overview of the risks and benefits of vaccines. Health care
providers who administer vaccines are required by law to provide
patients with the most up-to-date version of the VIS for any
vaccine covered under the National Childhood Vaccine Injury
Act (NCVIA). The CMS-1500 and CMS-855B are forms required by
the Centers for Medicare and Medicaid Services (CMS) for billing
and enrolling as a Medicare provider, respectively. The PHS-731 is
now the CDC 731 form and is the International Certificate of
